Frontiers in bioscience (Elite edition)HumansBiosimilar PharmaceuticalsGenital NeoplasmsFemaleCost-Benefit Analysis
Biosimilars in Gynecologic Cancers: Basic Principles and New Horizons.
Mariem Galuia, Azhar Hussain, Sarfraz Ahmad
Published: 202510.31083/FBE33415
Abstract
Biological therapies have transformed cancer treatment by targeting the molecular mechanisms involved in carcinogenesis. However, higher costs, limited accessibility, and supply chain disruptions-such as those caused by COVID-19 in recent years-under…
Preview only. Read the full abstract at the source